Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $170M; returns 1 day -3.6%, 1 week -0.7%, 1 year -75.8%.

Organogenesis Holdings Inc. is a leading regenerative medicine company focused on developing, manufacturing, and commercializing product solutions primarily for the Advanced Wound Care (AWC) and, to a lesser extent, Surgical & Sports Medicine (SSM) markets.

Groups ORGO belongs to

• Regenerative Medicine
• Healthcare
• Biotechnology
• Life Sciences
• Biologics
• Medical Devices
• Advanced Materials
• Materials Science
• Healthcare Services

ORGO financial model: income statement, cash flow and balance sheet